If we are still stuffing around like now wishing for some FDA approvals and suggesting the business is on a sound footing because xyz will happen in the future, I hope Stephen Mayne is at the AGM in November calling for heads to roll. I will second him. A company like this one should be more than a couple of deals done in second half of 2019 with Mithra.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)